Heparin protects against septic mortality via apoE-antagonism

American Journal of Surgery

Volumn 202, Issue 3, 2011, Pages 325-335

  Chuang, Kelley I ^a   Leung, Briana ^a   Hsu, Nancy ^a   Harris, Hobart W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apolipoprotein E; Cecal ligation and puncture; Heparin; Low density lipoprotein receptor; Natural killer T cells; Sepsis

Indexed keywords

ALANINE AMINOTRANSFERASE; APOLIPOPROTEIN E; CYTOKINE; HEPARIN; LEPIRUDIN; LOW DENSITY LIPOPROTEIN RECEPTOR; SODIUM CHLORIDE; THROMBOPLASTIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANTICOAGULATION; ARTICLE; BINDING SITE; BLOOD SAMPLING; CECAL LIGATION AND PUNCTURE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG INFUSION; DRUG INHIBITION; FIBROBLAST; FLUORESCENCE ACTIVATED CELL SORTING; INCUBATION TIME; INTERNALIZATION; LIGATION; LIVER; MALE; MORTALITY; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN TRANSPORT; PUNCTURE; SEPSIS; SURVIVAL RATE;

ALANINE TRANSAMINASE; ANIMALS; ANTICOAGULANTS; ANTIGEN-PRESENTING CELLS; APOLIPOPROTEINS E; BLOTTING, WESTERN; CECUM; CYTOKINES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLOW CYTOMETRY; HEPARIN; HIRUDINS; INFLAMMATION; LIGATION; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NATURAL KILLER T-CELLS; OLIGOSACCHARIDES; PUNCTURES; RECEPTORS, LDL; RECOMBINANT PROTEINS;

EID: 80052146064     PISSN: 00029610     EISSN: 18791883     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2010.10.017     Document Type: Article

References (39)

1. N. de Bont, M.G. Netea, and P.N. Demacker Apolipoprotein E-deficient mice have an impaired immune response to Klebsiella pneumoniae Eur J Clin Invest 30 2000 818 822
2. S.E. Roselaar, and A. Daugherty Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo J Lipid Res 39 1998 1740 1743 (Pubitemid 28411160)
3. M. Van Oosten, P.C. Rensen, and E.S. Van Amersfoort Apolipoprotein E protects against bacterial lipopolysaccharide-induced lethality A new therapeutic approach to treat gram-negative sepsis J Biol Chem 276 2001 8820 8824
4. O.M. Kattan, F.B. Kasravi, and E.L. Elford Apolipoprotein E-mediated immune regulation in sepsis J Immunol 181 2008 1399 1408
5. P. van den Elzen, S. Garg, and L. Leon Apolipoprotein-mediated pathways of lipid antigen presentation Nature 437 2005 906 910 (Pubitemid 41486768)
6. M. Taniguchi, K. Seino, and T. Nakayama The NKT cell system: bridging innate and acquired immunity Nat Immunol 4 2003 1164 1165 (Pubitemid 37540684)
7. J. Dong, C.A. Peters-Libeu, and K.H. Weisgraber Interaction of the N-terminal domain of apolipoprotein E4 with heparin Biochemistry 40 2001 2826 2834 (Pubitemid 32198284)
8. C.P. Libeu, S. Lund-Katz, and M.C. Phillips New insights into the heparan sulfate proteoglycan-binding activity of apolipoprotein E J Biol Chem 276 2001 39138 39144
9. K.H. Weisgraber, S.C. Rall Jr, and R.W. Mahley Human apolipoprotein E Determination of the heparin binding sites of apolipoprotein E3 J Biol Chem 261 1986 2068 2076 (Pubitemid 17205129)
10. J.E. Croy, T. Brandon, and E.A. Komives Two apolipoprotein E mimetic peptides, ApoE(130-149) and ApoE(141-155)2, bind to LRP1 Biochemistry 43 2004 7328 7335 (Pubitemid 38745750)
11. H. Watarai, R. Nakagawa, and M. Omori-Miyake Methods for detection, isolation and culture of mouse and human invariant NKT cells Nat Protoc 3 2008 70 78
12. R. Sakiyama, K. Fukuta, and K. Matsumoto Stimulation of hepatocyte growth factor production by heparin-derived oligosaccharides J Biochem 141 2007 653 660 (Pubitemid 47014013)
13. A. Greinacher, H. Volpel, and U. Janssens Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study Circulation 99 1999 73 80 (Pubitemid 29035960)
14. T. Tanaka, T. Tsujinaka, and J. Kambayashi The effect of heparin on multiple organ failure and disseminated intravascular coagulation in a sepsis model Thromb Res 60 1990 321 330
15. C.J. Wiedermann Clinical review: molecular mechanisms underlying the role of antithrombin in sepsis Crit Care 10 2006 209
16. J. Hermida, R. Montes, and J.A. Paramo Endotoxin-induced disseminated intravascular coagulation in rabbits: effect of recombinant hirudin on hemostatic parameters, fibrin deposits, and mortality J Lab Clin Med 131 1998 77 83 (Pubitemid 28065771)
17. J.M. Pearson, A.E. Schultze, and K.A. Schwartz The thrombin inhibitor, hirudin, attenuates lipopolysaccharide-induced liver injury in the rat J Pharmacol Exp Ther 278 1996 378 383 (Pubitemid 27167117)
18. N. Chand, and A.J. Sanyal Sepsis-induced cholestasis Hepatology 45 2007 230 241 (Pubitemid 46144383)
19. P.Y. Bochud, and T. Calandra Pathogenesis of sepsis: new concepts and implications for future treatment BMJ 326 2003 262 266 (Pubitemid 36169594)
20. N.C. Riedemann, R.F. Guo, and P.A. Ward Novel strategies for the treatment of sepsis Nat Med 9 2003 517 524 (Pubitemid 36597096)
21. G.R. Bernard, J.L. Vincent, and P.F. Laterre Efficacy and safety of recombinant human activated protein C for severe sepsis N Engl J Med 344 2001 699 709 (Pubitemid 32204987)
22. R.A. Gaskins Jr, and F.G. Dalldorf Experimental meningococcal septicemia Effect of heparin therapy Arch Pathol Lab Med 100 1976 318 324 (Pubitemid 8190710)
23. M.P. Griffin, D.C. Gore, and J.B. Zwischenberger Does heparin improve survival in experimental porcine gram-negative septic shock? Circ Shock 31 1990 343 349 (Pubitemid 20220911)
24. J. Meyer, C.S. Cox, and D.N. Herndon Heparin in experimental hyperdynamic sepsis Crit Care Med 21 1993 84 89 (Pubitemid 23028480)
25. D.G. Remick, D.E. Newcomb, and G.L. Bolgos Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture Shock 13 2000 110 116
26. R. Zarychanski, S. Doucette, and D. Fergusson Early intravenous unfractionated heparin and mortality in septic shock Crit Care Med 36 2008 2973 2979
27. F. Jaimes, G. De La Rosa, and C. Morales Unfractioned Heparin for Treatment of Sepsis: A Randomized Clinical Trial (the HETRASE study) Crit Care Med 37 2009 1185 1196
28. C. Zhao, Z.D. Zhang, and X.J. Zhang Evaluation of clinical effects on low-dose heparin therapy for sepsis [article in Chinese] Zhonghua Nei Ke Za Zhi 48 2009 566 569
29. B.L. Warren, A. Eid, and P. Singer Caring for the critically ill patient High-dose antithrombin III in severe sepsis: a randomized controlled trial JAMA 286 2001 1869 1878 (Pubitemid 33010239)
30. C.J. Wiedermann, J.N. Hoffmann, and M. Juers High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: efficacy and safety Crit Care Med 34 2006 285 292 (Pubitemid 43145602)
31. J.J. Corrigan Jr, and C.M. Jordan Heparin therapy in septicemia with disseminated intravascular coagulation N Engl J Med 283 1970 778 782
32. J.J. Corrigan Jr, and J.F. Kiernat Effect of heparin in experimental gram-negative septicemia J Infect Dis 131 1975 138 143
33. T. Pernerstorfer, U. Hollenstein, and J.B. Hansen Lepirudin blunts endotoxin-induced coagulation activation Blood 95 2000 1729 1734 (Pubitemid 30120836)
34. R.W. Mahley, and Z.S. Ji Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E J Lipid Res 40 1999 1 16 (Pubitemid 29022581)
35. R.J. Rhee, S. Carlton, and J.L. Lomas Inhibition of CD1d activation suppresses septic mortality: a role for NK-T cells in septic immune dysfunction J Surg Res 115 2003 74 81 (Pubitemid 37323951)
36. R. Lever, J.R. Hoult, and C.P. Page The effects of heparin and related molecules upon the adhesion of human polymorphonuclear leucocytes to vascular endothelium in vitro Br J Pharmacol 129 2000 533 540 (Pubitemid 30083875)
37. L. Giuffre, A.S. Cordey, and N. Monai Monocyte adhesion to activated aortic endothelium: role of L-selectin and heparan sulfate proteoglycans J Cell Biol 136 1997 945 956 (Pubitemid 27098749)
38. A. Koenig, K. Norgard-Sumnicht, and R. Linhardt Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents J Clin Invest 101 1998 877 889 (Pubitemid 28096085)
39. S.M. Watt, J. Williamson, and H. Genevier The heparin binding PECAM-1 adhesion molecule is expressed by CD34+ hematopoietic precursor cells with early myeloid and B-lymphoid cell phenotypes Blood 82 1993 2649 2663 (Pubitemid 23318071)